28-Mar-2024
Surgery Partners, Inc. Announces Pricing of New Senior Notes Offering
Globe Newswire (Tue, 26-Mar 3:51 PM ET)
Surgery Partners Subsidiary Announces $600M Notes Offering
TipRanks (Tue, 26-Mar 8:44 AM ET)
Surgery Partners to offer $600M senior unsecured notes
Seeking Alpha News (Tue, 26-Mar 8:39 AM ET)
Surgery Partners, Inc. Announces New Senior Notes Offering
Globe Newswire (Tue, 26-Mar 8:21 AM ET)
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance
Globe Newswire (Mon, 26-Feb 7:30 AM ET)
Globe Newswire (Thu, 8-Feb 4:05 PM ET)
Globe Newswire (Mon, 8-Jan 7:30 AM ET)
Surgery Partners, Inc. to Present at Upcoming Investor Conference
Globe Newswire (Fri, 5-Jan 1:40 PM ET)
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Surgery Partners trades on the NASDAQ stock market under the symbol SGRY.
As of March 28, 2024, SGRY stock price declined to $29.83 with 715,743 million shares trading.
SGRY has a beta of 2.40, meaning it tends to be more sensitive to market movements. SGRY has a correlation of 0.32 to the broad based SPY ETF.
SGRY has a market cap of $3.78 billion. This is considered a Mid Cap stock.
Last quarter Surgery Partners reported $735 million in Revenue and $.44 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.06.
In the last 3 years, SGRY stock traded as high as $69.58 and as low as $20.46.
The top ETF exchange traded funds that SGRY belongs to (by Net Assets): VTI, VB, IWM, VBK, VXF.
SGRY has underperformed the market in the last year with a return of -6.5%, while the SPY ETF gained +33.6%. In the last 3 month period, SGRY fell short of the market, returning -7.7%, while SPY returned +10.1%. However, in the most recent 2 weeks SGRY has outperformed the stock market by returning +4.0%, while SPY returned +1.7%.
SGRY support price is $29.22 and resistance is $30.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGRY stock will trade within this expected range on the day.